SCHEMBL802795

SCHEMBL802795

CNCCc1cc(Nc2n[nH]c(C3CC3)n2)nc(-c2ccccc2Cl)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
IGF1R P08069 7/20 0.36
CYP1A2 P05177 3/20 0.34
CYP3A4 P08684 3/20 0.34
CYP2C19 P33261 3/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 1/20 0.34
BRAF P15056 1/20 0.34
GBA1 P04062 1/20 0.33
MAPK1 P28482 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
PLK4 O00444 1/20 0.32
PAK4 O96013 1/20 0.32
MAT2A P31153 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL805609 0.88 ALDH1A1 (0.34) ALDH1A1NPC1RAB9ASMN1; SMN2IGF1R
SCHEMBL12620332 0.86 ALDH1A1 (0.33) ALDH1A1NPC1RAB9ASMN1; SMN2IGF1R
SCHEMBL801496 0.76 FADS1 (0.41) ALDH1A1NPC1RAB9ACYP1A2CYP3A4
SCHEMBL802834 0.68 ACP1 (0.41) ALDH1A1NPC1RAB9ASMN1; SMN2IGF1R
SCHEMBL802234 0.67 CYP1A2 (0.49) ALDH1A1CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL801829 0.67 ADORA3 (0.39) ALDH1A1IGF1RCYP1A2CYP3A4CYP2C19
SCHEMBL802439 0.67 CYP1A2 (0.53) ALDH1A1NPC1RAB9ASMN1; SMN2IGF1R
SCHEMBL802458 0.67 CYP1A2 (0.53) ALDH1A1CYP1A2CYP3A4CYP2C19CYP2D6
SCHEMBL802416 0.67 USP1 (0.41) ALDH1A1SMN1; SMN2IGF1RCYP1A2CYP3A4
SCHEMBL12653472 0.65 FADS1 (0.38) ALDH1A1CYP1A2CYP3A4CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8633210-B2 Triazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-01-21 US disclosed
US-20120071657-A1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-03-22 US disclosed
US-7473691-B2 Pyrazole compounds useful as protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2009-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071657-A1 TRIAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS GSK3B, GSK3A, CDK19 ALDH1A1 4768/4885NPC1 2844/4885RAB9A 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.